Cidara Therapeutics (CDTX) News Today $62.64 -0.26 (-0.41%) As of 03:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Cidara Therapeutics (CDTX) Projected to Post Quarterly Earnings on ThursdayJuly 31, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Reaches New 12-Month High - Here's WhyJuly 25, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Stock Crosses Above 50 Day Moving Average - What's Next?July 25, 2025 | marketbeat.comCidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025July 24, 2025 | globenewswire.comCidara Therapeutics (NASDAQ:CDTX) Sets New 52-Week High - What's Next?July 19, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Share Price Passes Above 50-Day Moving Average - Here's WhyJuly 16, 2025 | marketbeat.comCidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of "Buy" from BrokeragesJuly 16, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Shares Down 7.6% - What's Next?July 15, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Trading 5.9% Higher - Still a Buy?July 14, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Sees Strong Trading Volume - Here's WhyJuly 9, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Shares Gap Down - Here's What HappenedJuly 8, 2025 | marketbeat.comSegal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara TherapeuticsJuly 7, 2025 | businesswire.comWarner Bros., Cidara, LENZ Therapeutics, and More Stocks See Action From Activist InvestorsJuly 3, 2025 | msn.comCidara Therapeutics (NASDAQ:CDTX) Sees Strong Trading Volume - What's Next?July 2, 2025 | marketbeat.comCidara Therapeutics Added to Russell 2000 and Russell 3000 Indexes Recognizing Corporate Progress - NasdaqJuly 2, 2025 | nasdaq.comCidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)July 1, 2025 | globenewswire.comInsider Buying: Cidara Therapeutics, Inc. (NASDAQ:CDTX) Director Buys 2,272,727 Shares of StockJuly 1, 2025 | insidertrades.comRa Capital Management, L.P. Purchases 2,272,727 Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX) StockJune 30, 2025 | marketbeat.comBiotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains (CDTX)With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?June 30, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Stock Price Down 5% - Should You Sell?June 30, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Given "Market Outperform" Rating at JMP SecuritiesJune 30, 2025 | marketbeat.comCidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® IndexesJune 30, 2025 | globenewswire.comCidara Therapeutics Inc (CDTX) - Investing.com UKJune 29, 2025 | uk.investing.comCidara Therapeutics, Inc. (CDTX) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comCidara Therapeutics Closes Public Offering of 9.1 Million Shares, Raising $402.5 Million - NasdaqJune 27, 2025 | nasdaq.comCidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesJune 26, 2025 | uk.finance.yahoo.comCidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesJune 26, 2025 | globenewswire.comCidara Therapeutics (NASDAQ:CDTX) Sees Strong Trading Volume - Still a Buy?June 26, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Shares Gap Down - Time to Sell?June 25, 2025 | marketbeat.comCidara Therapeutics Advances CD388 To Phase 3, Reiterate BuyJune 25, 2025 | seekingalpha.comCidara Therapeutics prices upsized $350 milion stock offering at $44June 25, 2025 | msn.comCidara Announces Pricing of Upsized Public Offering of Common StockJune 24, 2025 | globenewswire.comCidara reports outcomes from trial of CD388 for preventing seasonal influenzaJune 24, 2025 | msn.comCDTX Stock Quote Price and Forecast | CNNJune 24, 2025 | cnn.comRoyal Bank Of Canada Forecasts Strong Price Appreciation for Cidara Therapeutics (NASDAQ:CDTX) StockJune 24, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Reaches New 1-Year High After Analyst UpgradeJune 24, 2025 | marketbeat.comCidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $68.00 at GuggenheimJune 24, 2025 | marketbeat.comCidara Therapeutics Inc.June 23, 2025 | wsj.comCidara Therapeutics stock falls after proposed public offering announcementJune 23, 2025 | uk.investing.comCidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage TrialJune 23, 2025 | msn.comCidara Announces Proposed Public Offering of Common StockJune 23, 2025 | globenewswire.comCidara Shares Soar Premarket After Positive Influenza Trial ResultsJune 23, 2025 | marketwatch.comCidara Therapeutics stock rockets after positive flu prevention trial resultsJune 23, 2025 | in.investing.comCidara Launches 93% As A Universal Flu Shot Becomes A Closer RealityJune 23, 2025 | msn.comCidara Therapeutics (NASDAQ:CDTX) Shares Gap Up Following Analyst UpgradeJune 23, 2025 | marketbeat.comCidara Therapeutics' (CDTX) Strong-Buy Rating Reaffirmed at WBB SecuritiesJune 23, 2025 | marketbeat.comNeedham & Company LLC Issues Positive Forecast for Cidara Therapeutics (NASDAQ:CDTX) Stock PriceJune 23, 2025 | marketbeat.comWhy Is Cidara Therapeutics Stock Trading Higher On Monday?June 23, 2025 | benzinga.comTraders Buy High Volume of Put Options on Cidara Therapeutics (NASDAQ:CDTX)June 23, 2025 | marketbeat.comCidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal InfluenzaJune 23, 2025 | globenewswire.com Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address CDTX Media Mentions By Week CDTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDTX News Sentiment▼0.000.46▲Average Medical News Sentiment CDTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDTX Articles This Week▼13▲CDTX Articles Average Week Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Axsome Therapeutics News Today Telix Pharmaceuticals News Today Vaxcyte News Today Merus News Today Cytokinetics News Today Avidity Biosciences News Today ADMA Biologics News Today Krystal Biotech News Today Metsera News Today Abivax News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDTX) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDTX Stock Alerts